Wearable Biosensors Stocks: The Guide to Health Technology as Investment

Wearable biosensors stocks are shares in publicly traded companies that develop, produce, or distribute wearable devices for continuous health monitoring. These sensors measure heart rate, blood sugar, oxygen saturation, and blood pressure in real time. The global market was approximately $31.6 billion in 2024 and is expected to grow to about $66.2 billion by 2034, at an annual growth rate between 7.7 and 8.2 percent.

What Wearable Biosensors Do Technically

A biosensor converts a biological signal into measurable electronic data. Placed on the wrist, on the skin, or subcutaneously, the sensors continuously record physiological values without requiring blood draws in a laboratory.

Core Measurement Parameters

Modern devices monitor several vital functions simultaneously. The most common measurements are:

• Heart rate and heart rhythm
• Blood sugar via continuous glucose monitoring
• Oxygen saturation (SpO2)
• Blood pressure measurement and skin temperature

Electrochemical Sensors as the Main Driver

Electrochemical biosensors are growing at the fastest rate of 12.1 percent. In 2024, they held a market share of 23.7 percent, driven by broad adoption of continuous glucose monitoring.

Nano-Biosensors and Their Role

Nano-biosensors increase sensitivity and reduce form factor. These sensors enable diagnostics that were previously only conceivable in clinical settings to be performed directly on the body.

The Market for Health Technology Stocks in 2026

Those interested in health technology stocks in 2026 encounter a sector with stable, structural growth. An aging population in developed countries and the spread of chronic diseases drive demand sustainably.

Key Market Figures at a Glance

The central figures demonstrate the segment's potential:

• Global market value 2024: approximately $31.6 billion
• Forecast 2034: approximately $66.2 billion
• East Asia market share 2024: approximately 36.5 to 38.5 percent
• North America market share 2024: approximately 27.5 to 28.6 percent

Regional Growth Markets

East Asia leads the market, particularly Japan with its aging society. The Japanese market is expected to grow from $2.9 billion (2024) to $6.6 billion (2034), at a growth rate of 8.5 percent.

Why the Sector Grows Structurally

Remote patient monitoring and integration into telehealth platforms accelerate adoption. The lingering effects of COVID-19 have embedded digital health solutions in medical practices and households.

Pure Biosensor and Medical Device Stocks

Specialists benefit directly from growth but carry higher single-company risk. Those investing specifically in medical device stocks should track companies' regulatory pipelines.

Dexcom as CGM Market Leader

Dexcom Inc. (DXCM) holds approximately 74 percent of the U.S. continuous glucose monitoring market. Products such as Dexcom G7 and the G7 15 Day extend wear time to over 15 days. In February 2024, the company received an FDA warning letter regarding manufacturing deficiencies.

Abbott and the Over-the-Counter Turn

Abbott Laboratories (ABT) operates the FreeStyle Libre system. In June 2024, the manufacturer received FDA approval for Libre Rio, the first over-the-counter CGM system. This opens consumer access to direct purchase without a physician prescription.

Medtronic, iRhythm, and Lantheus Holdings

Medtronic plc (MDT) supplies Guardian Connect sensors and MiniMed systems. iRhythm Technologies (IRTC) develops wearable biosensors for diagnosing heart rhythm disorders. Lantheus Holdings expands the field of imaging and diagnostic health technology. These stocks react strongly to individual approval decisions.

Apple Health Technology in Investment Focus

Apple Inc. (AAPL) combines hardware, software, and services into a closed ecosystem. The Apple Watch measures heart rate, SpO2, and ECG. For investors, Apple Health Technology is less a pure biosensor business than a component of a broad technology conglomerate.

What the Health App Can Do

The Health App consolidates performance data from smartwatch, smartphones, and connected devices. Users see trends in sleep, activity, and heart health in one place. Features include notifications for irregular heart rhythm and fall detection.

How Cardiologists Assess the Measurements

The Apple Watch's ECG function can detect signs of atrial fibrillation but does not replace clinical diagnostics. Physicians use the data as supplementary information, not as the sole basis for decisions.

Costs and Usage

The Health App itself is free and preinstalled on every compatible iPhone. Costs arise from the devices and optional services. For stock valuation, revenue from the services segment, which grows steadily, is most important.

Samsung Wearables and the Galaxy Ecosystem

Samsung Electronics integrates health sensors into the Galaxy line. Samsung Wearables such as the Galaxy Watch measure heart rate, blood pressure, and body composition. For investors, Samsung is a diversified electronics conglomerate with a relevant health segment.

The Galaxy Wearable App

The Galaxy Wearable App connects the smartwatch and smartphones and controls device settings. It is available free in the Galaxy Store and Google Play. The app synchronizes performance data and allows management of notifications.

What the App Does

Without the Galaxy Wearable App, a Galaxy Watch cannot be fully set up. It provides the user manual, manages watch faces, and pairs sensors with the smartphone. Users can find details on compatibility and setup directly at samsung.com.

Google and the Android Foundation

Google provides Wear OS, the platform on which many Samsung Wearables run. The close integration of Samsung and Google influences features, updates, and the use of health services.

Suppliers and Component Manufacturers

Behind every wearable are sensors and chips. Suppliers benefit from cross-industry growth without bearing the end-customer risk of a single product.

Infineon, Texas Instruments, and TDK

Infineon Technologies AG (IFX) supplies sensor technology from Germany. Texas Instruments (TXN) produces semiconductors for biosensors. TDK Corporation manufactures sensor components. These companies form the technical backbone of the market.

Philips and Broadcom

Koninklijke Philips N.V. (PHG) develops medical wearables. Broadcom Inc. (AVGO) manufactures sensor chips. Both serve multiple customers and thus diversify their business risk.

The Role of Artificial Intelligence

Algorithms evaluate sensor data and recognize patterns before symptoms appear. The combination of artificial intelligence and biosensors shifts the market from pure measurement to prediction.

Predictive Health Models

Penn State received an NSF grant of $1.5 million in October 2024 to develop AI-powered biosensors. Such early warning systems are designed to detect disease before clinical symptoms manifest.

Real-Time Monitoring as Standard

Real-time monitoring transforms one-off measurements into continuous data streams. These solutions enable personalized applications that adapt to the wearer's lifestyle.

Industry Trends in Detail

Several developments shape the sector beyond pure revenue growth.

Over-the-Counter Access and Longer Operating Times

Libre Rio and Dexcom's Stelo biosensor open the market to consumers without a prescription. At the same time, manufacturers extend wear time, reducing cost per day.

Femtech and New Applications

Global investment in femtech exceeded $3 billion annually in the mid-2020s. Hormone-monitoring sensors form their own growth segment. Environment and food monitoring also use the technology.

Online Distribution

Around 35 percent of health-conscious buyers preferred online purchases of wearable biosensors in 2024. The shopping cart is increasingly shifting to online channels.

Sector Challenges

Despite growth, risks remain concrete and should factor into valuations.

Costs and Regulatory Hurdles

High product costs burden many patients. FDA and EMA approvals decide market entry, and quality deficiencies lead to warnings. Manufacturing under strict regulations binds considerable resources.

Accuracy and User Knowledge

Sensor placement strongly influences accuracy. FreeStyle Libre sensors work reliably on the upper arm but insufficiently on the abdomen. Lack of user knowledge also diminishes the practical value of the devices.

Competition and Patent Risks

Traditional point-of-care biosensors continue to enjoy trust among professionals. Patent disputes hold both opportunities and risks. Companies without annual iterations lose customers to competitors with better battery life.

ETFs as Broad Access

Those wishing to diversify single-company risk find access to the entire segment through ETFs. Health and technology ETFs bundle many stocks in one fund.

Benefits of Diversification

ETFs smooth out fluctuations in individual stocks. A mix of pure biosensor companies and broad technology conglomerates significantly reduces concentration risk.

What to Watch When Selecting

Review the composition, ongoing costs, and the fund's currency. A U.S.-heavy ETF carries currency risk that can change returns in euros.

How Investors Approach the Topic via aktie.com

On aktie.com, users track over 10,000 assets in real time, including stocks, ETFs, and other instruments. Daily analyses and guides classify developments in the health sector.

Data and Tools

The dashboard consolidates price data, figures, and estimates clearly. The AI financial assistant answers questions about individual stocks and analyzes risks based on current data.

Learning and Interpretation

Knowledge modules explain basics from stocks to ETF savings plans. The portfolio simulator allows backtesting and a diversification score before real capital is deployed.

Our Three-Step Framework for Evaluating a Company

To classify wearable biosensors stocks, we use a clear process in our analyses.

Step 1: Check the Business Model

Is the company a pure specialist or a broad conglomerate? Specialists grow faster but fluctuate more. Review revenue, profit, and the fiscal year.

Step 2: Pipeline and Approvals

Approvals are stock catalysts. Track the regulatory pipeline and the fiscal year-end when companies release performance data.

Step 3: Competition and Differentiation

Evaluate technological advantages such as longer operating times or multi-analyte capability. Companies with clear differentiation defend margins better.

Practical Access via a Broker

The purchase of individual stocks or ETFs is conducted through a broker. Compare fees, available trading venues, and settlement in the respective currency.

Compare Depot Features

Pay attention to depot features such as savings plans, limit orders, and an overview of your holdings. Many providers bundle mobile services in an app for on-the-go access.

Costs and Transparency

Order fees and spreads reduce returns. Read the terms and the privacy policy before opening an account.

Reliable Sources for Context

For current prices and figures, established financial portals such as finanzen.net provide a solid foundation. Additional industry overviews help compare trends across multiple segments.

Reading Figures Correctly

Earnings per share, revenue growth, and forecasts for the next fiscal year provide clues to valuation. A symbol or ticker uniquely identifies each security.

Further Topics

Those examining leveraged products will find a classification under Derivatives explained simply. Tax aspects are covered in the article on Tax brackets in Germany.

Frequently Asked Questions

What Role Does North America Play in the Market?

North America held approximately 27.5 to 28.6 percent of the market in 2024, supported by strict regulation, advanced research, and clinical integration.

Why Doesn't the Health App Work Sometimes?

Usually it's due to missing permissions, an outdated software version, or a broken connection between smartphone and smartwatch. A restart and update often fix the errors.

Is the Galaxy Wearable App Free?

Yes. The app is available free in the Galaxy Store and Google Play and is required to set up a Galaxy Watch.

Are Individual Stocks or ETFs Better?

Individual stocks offer higher upside with higher risk. ETFs diversify across many companies and suit investors who want broad segment exposure.

What Trends Drive Growth in 2026?

Over-the-counter access, longer sensor operating times, integration with artificial intelligence, and demand in East Asia are among the strongest drivers.

Context for Your Own Strategy

The sector offers structural growth but demands patience and clear risk diversification. Combining specialists, broad conglomerates, and suppliers covers different parts of the value chain. aktie.com provides no investment advice; all information is for information purposes and without warranty.